Augmenix was founded by Incept, a holding company set up by Amar Sawhney and Fred Khosravi to hold the patents on water-based gels, in 2008.
Varian Medical Systems, a New York-listed supplier of medical technology for treating cancer with radiotherapy, has invested $15m in US-based peer Augmenix for a minority stake but with a milestone-based option to buy out the remaining shares.
Augmenix was founded by Incept, a holding company set up by Amar Sawhney and Fred Khosravi to hold the patents on water-based gels, in 2008. Centure capital firms Ascension Health Ventures, Catalyst Health Ventures, Pinnacle Ventures, and the Sparta Group initially funded Augmenix.
…
